Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9,101 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pharmacological Treatment of Schizophrenia: Japanese Expert Consensus.
Sakurai H, Yasui-Furukori N, Suzuki T, Uchida H, Baba H, Watanabe K, Inada K, Kikuchi YS, Kikuchi T, Katsuki A, Kishida I, Kato M. Sakurai H, et al. Among authors: kato m. Pharmacopsychiatry. 2021 Mar;54(2):60-67. doi: 10.1055/a-1324-3517. Epub 2021 Jan 12. Pharmacopsychiatry. 2021. PMID: 33434943 Free PMC article.
The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot Trial.
Koshikawa Y, Takekita Y, Kato M, Sakai S, Onohara A, Sunada N, Nishida K, Yoshimura M, Fabbri C, Serretti A, Kinoshita T. Koshikawa Y, et al. Among authors: kato m. Neuropsychobiology. 2016;73(1):35-42. doi: 10.1159/000442209. Epub 2016 Jan 27. Neuropsychobiology. 2016. PMID: 26812618 Clinical Trial.
Pharmacological management of depression: Japanese expert consensus.
Sakurai H, Uchida H, Kato M, Suzuki T, Baba H, Watanabe K, Inada K, Kikuchi T, Katsuki A, Kishida I, Sugawara Kikuchi Y, Yasui-Furukori N; Medical Education Panel of the Japanese Society of Clinical Neuropsychopharmacology. Sakurai H, et al. Among authors: kato m. J Affect Disord. 2020 Apr 1;266:626-632. doi: 10.1016/j.jad.2020.01.149. Epub 2020 Jan 28. J Affect Disord. 2020. PMID: 32056937 Free article.
Factors Associated with Non-Remission in Bipolar Disorder: The Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Outpatient Clinics (MUSUBI).
Tsuboi T, Suzuki T, Azekawa T, Adachi N, Ueda H, Edagawa K, Katsumoto E, Kubota Y, Goto E, Hongo S, Watanabe Y, Kato M, Yasui-Furukori N, Yoshimura R, Nakagawa A, Kikuchi T, Watanabe K. Tsuboi T, et al. Among authors: kato m. Neuropsychiatr Dis Treat. 2020 Mar 31;16:881-890. doi: 10.2147/NDT.S246136. eCollection 2020. Neuropsychiatr Dis Treat. 2020. PMID: 32280229 Free PMC article.
Pharmacological management of bipolar disorder: Japanese expert consensus.
Sakurai H, Kato M, Yasui-Furukori N, Suzuki T, Baba H, Watanabe K, Inada K, Kishida I, Sugawara Kikuchi Y, Kikuchi T, Katsuki A, Uchida H; Medical Education Panel of the Japanese Society of Clinical Neuropsychopharmacology. Sakurai H, et al. Among authors: kato m. Bipolar Disord. 2020 Dec;22(8):822-830. doi: 10.1111/bdi.12959. Epub 2020 Jul 2. Bipolar Disord. 2020. PMID: 32558145 Free PMC article.
Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients: A multicenter treatment survey for bipolar disorder in psychiatric clinics (MUSUBI).
Kato M, Adachi N, Kubota Y, Azekawa T, Ueda H, Edagawa K, Katsumoto E, Goto E, Hongo S, Tsuboi T, Yasui-Furukori N, Yoshimura R, Nakagawa A, Kikuchi T, Kinoshita T, Watanabe Y, Miki K, Watanabe K. Kato M, et al. J Psychiatr Res. 2020 Dec;131:228-234. doi: 10.1016/j.jpsychires.2020.09.030. Epub 2020 Sep 30. J Psychiatr Res. 2020. PMID: 33022523
Estimated model of psychotropic polypharmacy for bipolar disorder: Analysis using patients' and practitioners' parameters in the MUSUBI study.
Adachi N, Azekawa T, Edagawa K, Goto E, Hongo S, Kato M, Katsumoto E, Kikuchi T, Kubota Y, Miki K, Nakagawa A, Tsuboi T, Ueda H, Watanabe K, Watanabe Y, Yasui-Furukori N, Yoshimura R. Adachi N, et al. Among authors: kato m. Hum Psychopharmacol. 2021 Mar;36(2):e2764. doi: 10.1002/hup.2764. Epub 2020 Oct 22. Hum Psychopharmacol. 2021. PMID: 33089907
Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder.
Yasui-Furukori N, Adachi N, Kubota Y, Azekawa T, Goto E, Edagawa K, Katsumoto E, Hongo S, Ueda H, Miki K, Kato M, Yoshimura R, Nakagawa A, Kikuchi T, Tsuboi T, Watanabe K, Shimoda K. Yasui-Furukori N, et al. Among authors: kato m. Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):599-606. doi: 10.9758/cpn.2020.18.4.599. Clin Psychopharmacol Neurosci. 2020. PMID: 33124592 Free PMC article.
9,101 results